Human Immunodeficiency Virus  >>  Cytovene (ganciclovir)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cytovene (ganciclovir) / Roche
NCT00000989: The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS

Completed
2
50
US
Zidovudine, Sargramostim, Ganciclovir
National Institute of Allergy and Infectious Diseases (NIAID), Schering-Plough, Hoffmann-La Roche
Cytomegalovirus Retinitis, HIV Infections
 
07/92
NCT00001034: The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV

Completed
2
850
US
Ganciclovir
National Institute of Allergy and Infectious Diseases (NIAID), Hoffmann-La Roche
Cytomegalovirus Retinitis, HIV Infections, Gastrointestinal Diseases
 
08/95
NCT00001061: Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS

Completed
2
167
US
Sevirumab, Foscarnet sodium, Ganciclovir
National Institute of Allergy and Infectious Diseases (NIAID), Facet Biotech
Cytomegalovirus Retinitis, HIV Infections
 
03/98

Download Options